Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 1 | uM | 9 | 5000.00 | 2808.68 | 7024.00 | 7055.25 | 0.9956 | 0.9933 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 5559.00 | 7055.25 | 0.7879 | 0.6716 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7165.00 | 7055.25 | 1.0156 | 1.0234 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 5000.00 | 2808.68 | 3771.00 | 7055.25 | 0.5345 | 0.2482 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 7016.00 | 7055.25 | 0.9944 | 0.9916 |
| BT-20 | Erlotinib | 10 | uM | 9 | 5000.00 | 2808.68 | 3740.00 | 7055.25 | 0.5301 | 0.2405 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 4832.00 | 7055.25 | 0.6849 | 0.5043 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 5000.00 | 2808.68 | 7371.00 | 7055.25 | 1.0448 | 1.0670 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7026.00 | 7055.25 | 0.9959 | 0.9938 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7484.00 | 7055.25 | 1.0608 | 1.0908 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 5000.00 | 2808.68 | 7481.00 | 7055.25 | 1.0603 | 1.0902 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7125.00 | 7055.25 | 1.0099 | 1.0149 |
| BT-20 | Linsitinib | 10 | uM | 9 | 5000.00 | 2808.68 | 5819.00 | 7055.25 | 0.8248 | 0.7301 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7265.00 | 7055.25 | 1.0297 | 1.0446 | |
| BT-20 | Lapatinib | 1 | uM | 9 | 5000.00 | 2808.68 | 6029.00 | 7055.25 | 0.8545 | 0.7769 |
| BT-20 | Lapatinib | 10 | uM | 9 | 5000.00 | 2808.68 | 3193.00 | 7055.25 | 0.4526 | 0.1013 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 7416.00 | 7055.25 | 1.0511 | 1.0765 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 7419.00 | 7055.25 | 1.0516 | 1.0771 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 7088.00 | 7055.25 | 1.0046 | 1.0070 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 3666.00 | 7055.25 | 0.5196 | 0.2220 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7082.00 | 7055.25 | 1.0038 | 1.0057 | |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 89.00 | 119.50 | 0.7448 | 0.3497 | |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 156.25 | 71.09 | 94.00 | 119.50 | 0.7866 | 0.4518 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 171.00 | 119.50 | 1.4310 | 2.2265 |
| BT-20 | Linsitinib | 10 | uM | 9 | 156.25 | 71.09 | 94.00 | 119.50 | 0.7866 | 0.4518 |